Cadrenal Therapeutics
CVKD
#9731
Rank
S$42.86 M
Marketcap
$22.09
Share price
-1.18%
Change (1 day)
150.61%
Change (1 year)

EPS for Cadrenal Therapeutics (CVKD)

EPS in 2024 (TTM): -$9.25

According to Cadrenal Therapeutics's latest financial reports the company's current EPS (TTM) is -$9.13. In 2023 the company made an earnings per share (EPS) of -$12.22.

EPS history for Cadrenal Therapeutics from 2023 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$9.25-24.31%
2023-$12.22